This is an old revision of this page, as edited by Beetstra (talk | contribs) at 18:45, 9 January 2012 (Saving copy of the {{drugbox}} taken from revid 457630615 of page Tazarotene for the Chem/Drugbox validation project (updated: 'DrugBank').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:45, 9 January 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 457630615 of page Tazarotene for the Chem/Drugbox validation project (updated: 'DrugBank').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 457630615 of page Tazarotene with values updated to verified values. |
Clinical data | |
---|---|
Trade names | Tazorac |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | >99% |
Elimination half-life | 19 Hours |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C21H21NO2S |
Molar mass | 351.463 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |